[18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma
Tomography · 2023
DOI: 10.3390/tomography9010031 ↗At a glance
Journal article in Tomography, 2023. Written by Lighea Simona Airò Farulla and 11 co-authors. Institution: Division of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy. Major MEDLINE topics: Carcinoma, Renal Cell, Lung Neoplasms, Kidney Neoplasms. Cited 2 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Institute of Oncology Foundation (FIEO).
Abstract (original language)
Renal Cell Carcinoma (RCC) is generally characterized by low-FDG avidity, and [18F]FDG-PET/CT is not recommended to stage the primary tumor. However, its role to assess metastases is still unclear. The aim of this study was to evaluate the diagnostic accuracy of [18F]FDG-PET/CT in correctly identifying RCC lung metastases using histology as the standard of truth. The records of 350 patients affected by RCC were retrospectively analyzed. The inclusion criteria were: (a) biopsy- or histologically proven RCC; (b) Computed Tomography (CT) evidence of at least one lung nodule; (c) [18F]FDG-PET/CT performed prior to lung surgery; (d) lung surgery with histological analysis of surgical specimens; (e) complete follow-up available. A per-lesion analysis was performed, and diagnostic accuracy was reported as sensitivity and specificity, using histology as the standard of truth. [18F]FDG-PET/CT semiquantitative parameters (Standardized Uptake Value [SUVmax], Metabolic Tumor Volume [MTV] and Total Lesion Glycolysis [TLG]) were collected for each lesion. Sixty-seven patients with a total of 107 lesions were included: lung metastases from RCC were detected in 57 cases (53.3%), while 50 lesions (46.7%) were related to other lung malignancies. Applying a cut-off of SUVmax ≥ 2, the sensitivity and the specificity of [18F]FDG-PET/CT in detecting RCC lung metastases were 33.3% (95% CI: 21.4–47.1%) and 26% (95%CI: 14.6–40.3%), respectively. Although the analysis demonstrated a suboptimal diagnostic accuracy of [18F]FDG-PET/CT in discriminating between lung metastases from RCC and other malignancies, a semiquantitative analysis that also includes volumetric parameters (MTV and TLG) could support the correct interpretation of [18F]FDG-PET/CT images.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.
- Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.
- Division of Thoracic Surgery, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.
- Department of Statistics and Quantitative Methods, University of Milan-Bicocca, 20141 Milan, Italy.
ORCID profiles: Lighea Simona Airò Farulla, Laura Lavinia Travaini, Domenico Galetta, Samuele Frassoni, Lorenzo Muraglia
Funding
- European Institute of Oncology Foundation (FIEO)
Cite
APA
Airò Farulla, L. S., Travaini, L. L., Cuomo, M., Galetta, D., Mattana, F., Frassoni, S., Buonsanti, G., Muraglia, L., Zuccotti, G. A., Bagnardi, V., Spaggiari, L., & Ceci, F. (2023). [18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma. Tomography. https://doi.org/10.3390/tomography9010031
Vancouver
Airò Farulla LS, Travaini LL, Cuomo M, Galetta D, Mattana F, Frassoni S, et al. [18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma. Tomography. 2023. doi:10.3390/tomography9010031
BibTeX
@article{AirFarulla2023,
author = {Airò Farulla, Lighea Simona and Travaini, Laura Lavinia and Cuomo, Mariarosaria and Galetta, Domenico and Mattana, Francesco and Frassoni, Samuele and Buonsanti, Giuseppe and Muraglia, Lorenzo and Zuccotti, Giulia Anna and Bagnardi, Vincenzo and Spaggiari, Lorenzo and Ceci, Francesco},
title = {[18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma},
journal = {Tomography},
year = {2023},
doi = {10.3390/tomography9010031}
}
EUVIMED